CAPOZIDE 50/15(CAPTOPRIL; HYDROCHLOROTHIAZIDE)

药品名称	CAPOZIDE 50/15
申请号	018709	产品号	004
活性成分	CAPTOPRIL; HYDROCHLOROTHIAZIDE	市场状态	停止上市
剂型或给药途径	TABLET;ORAL	规格	50MG;15MG Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons
治疗等效代码		参比药物	否
批准日期	1984/10/12	申请机构	APOTHECON INC DIV BRISTOL MYERS SQUIBB
化学类型	New combination	审评分类	Standard review drug

与本品相关的专利信息（来自橙皮书Orange Book）
专利号	专利过期日	是否化合物专利	是否产品专利	专利用途代码	专利下载
无
历史专利信息
无

药品注册审批历史信息
申请号	修订号	审批结论	审批日期	审批内容
018709	035	AP	2009/02/26	Labeling Revision
018709	033	AP	2006/05/16	Labeling Revision
018709	031	AP	1997/05/20	Control Supplement
018709	030	AP	1998/06/03	Labeling Revision
018709	029	AP	1996/06/26	Manufacturing Change or Addition
018709	028	AP	1996/03/04	Control Supplement
018709	027	AP	1996/07/31	Labeling Revision
018709	026	AP	1996/07/31	Labeling Revision
018709	025	AP	1995/10/06	Manufacturing Change or Addition
018709	024	AP	1993/05/12	Package Change
018709	023	AP	1992/10/15	Labeling Revision
018709	022	AP	1992/06/25	Labeling Revision
018709	021	AP	1994/07/25	Labeling Revision
018709	020	AP	1992/03/05	Package Change
018709	019	AP	1991/12/10	Manufacturing Change or Addition
018709	018	AP	1990/09/05	Package Change
018709	017	AP	1991/03/21	Labeling Revision
018709	016	AP	1990/09/27	Labeling Revision
018709	015	AP	1989/05/03	Labeling Revision
018709	014	AP	1989/10/19	Labeling Revision
018709	012	AP	1988/06/22	Labeling Revision
018709	011	AP	1987/10/06	Control Supplement
018709	010	AP	1987/01/06	Package Change
018709	009	AP	1991/10/24	New or Modified Indication
018709	008	AP	1986/01/17	Labeling Revision
018709	007	AP	1985/08/02	Labeling Revision
018709	006	AP	1985/07/15	Package Change
018709	005	AP	1986/11/10	Control Supplement
018709	004	AP	1985/07/03	Package Change
018709	003	AP	1985/08/01	Package Change
018709	002	AP	1985/02/07	Package Change
018709	001	AP	1984/11/20	Control Supplement
018709	000	AP	1984/10/12	Approval